Higher expression of NFKB1 and SATB1, which are involved in regulating PD1 expression (Nixon and Li, 2017; Antonangeli et al., 2020) was only observed in patients with lower-grade gliomas. The gene discussed is SATB1; the disease is central nervous system cancer.